Cargando…
2786. Characterizing Ertapenem Neurotoxicity: A Systematic Review
BACKGROUND: Ertapenem is frequently used to treat ESBL-producing Enterobacterales infections. Although ertapenem has the highest incidence of delirium reported among antibiotics evaluated in a pharmacovigilance study of the FDA adverse event reporting system, little is known about clinical character...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677658/ http://dx.doi.org/10.1093/ofid/ofad500.2397 |